Journal for ImmunoTherapy of Cancer (Nov 2023)

714 Phase 1a trial of PLN-101095, an integrin αvβ8 and αvβ1 inhibitor, as monotherapy and in combination with pembrolizumab, in treatment-resistant patients with advanced or metastatic solid tumors

  • Mario Sznol,
  • Adil Daud,
  • Scott M Turner,
  • Chris N Barnes,
  • Susan Owen,
  • Eric A Lefebvre,
  • Hardean E Achneck

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0714
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.